These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14340436)

  • 1. EXPERIMENTAL VACCINE AGAINST KYASANUR FOREST DISEASE (KFD) VIRUS FROM MOUSE BRAIN SOURCE.
    MANSHARAMANI HJ; DANDAWATE CN; KRISHNAMURTHY BG; NANAVATI AN; JHALA HI
    Indian J Pathol Bacteriol; 1965 Jul; 12():159-77. PubMed ID: 14340436
    [No Abstract]   [Full Text] [Related]  

  • 2. EXPERIMENTAL INFECTION OF LACTATING MONKEYS WITH KYASANUR FOREST DISEASE VIRUS.
    SHAH KV
    Acta Virol; 1965 Jan; 9():71-5. PubMed ID: 14299358
    [No Abstract]   [Full Text] [Related]  

  • 3. KYASANUR FOREST DISEASE VIRUS IN THREE SPECIES ON RODENTS.
    WEBB HE
    Trans R Soc Trop Med Hyg; 1965 Mar; 59():205-11. PubMed ID: 14297196
    [No Abstract]   [Full Text] [Related]  

  • 4. INFECTION OF SHEEP AND MONKEYS WITH LANGAT VIRUS: CROSS-PROTECTION AGAINST OTHER VIRUSES OF THE RUSSIAN SPRING-SUMMER COMPLEX.
    O'REILLY KJ; SMITH CE; MCMAHON DA; WILSON AL; ROBERTSON JM
    J Hyg (Lond); 1965 Jun; 63(2):213-21. PubMed ID: 14308352
    [No Abstract]   [Full Text] [Related]  

  • 5. Serological response to Russian spring-summer encephalitis virus vaccine as measured with Kyasanur Forest disease virus.
    PAVRI KM; GOKHALE T; SHAH KV
    Indian J Med Res; 1962 Mar; 50():153-61. PubMed ID: 14484654
    [No Abstract]   [Full Text] [Related]  

  • 6. [LABORATORY INFECTION WITH KYASANUR FOREST DISEASE (KFD) VIRUS].
    JESSERER H; KUNZ C; PROHASKA E
    Klin Wochenschr; 1963 Oct; 41():1007-10. PubMed ID: 14094379
    [No Abstract]   [Full Text] [Related]  

  • 7. Kyasanur Forest Disease in India: innovative options for intervention.
    Rajaiah P
    Hum Vaccin Immunother; 2019; 15(10):2243-2248. PubMed ID: 30945970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental vaccine against Kyasanur Forest disease (KFD) virus from tissue culture source. I. Some data on the preparation and antigenicity tests of vaccines.
    Mansharamani HJ; Dandawate CN; Krishnamurthy BG
    Indian J Pathol Bacteriol; 1967 Jan; 10(1):9-24. PubMed ID: 6068256
    [No Abstract]   [Full Text] [Related]  

  • 9. Kyasanur Forest Disease (KFD): Rare Disease of Zoonotic Origin.
    Muraleedharan M
    J Nepal Health Res Counc; 2016 Sep; 14(34):214-218. PubMed ID: 28327690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and spatial distribution of Ixodid tick populations in the forest fringes of Western Ghats reported with human cases of Kyasanur forest disease and monkey deaths in South India.
    Sadanandane C; Gokhale MD; Elango A; Yadav P; Mourya DT; Jambulingam P
    Exp Appl Acarol; 2018 May; 75(1):135-142. PubMed ID: 29594846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental vaccine against Kyasanur Forest disease (KFD) virus from tissue culture source. II. Safety testing of the vaccine in cortisone sensitized Swiss albino mice.
    Mansharamani HJ; Dandawate CN
    Indian J Pathol Bacteriol; 1967 Jan; 10(1):25-32. PubMed ID: 6036490
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental vaccine against Kyasanur Forest Disease (KFD) virus from embryonated eggs. I. Adaptation of the virus to developing chick embryo and preparation of formolised vaccines.
    Dandawate CN; Mansharamani HJ; Jhala HI
    Indian J Pathol Bacteriol; 1965 Oct; 8(4):241-60. PubMed ID: 5850010
    [No Abstract]   [Full Text] [Related]  

  • 13. TRANSMISSION OF KYASANUR FOREST DISEASE VIRUS BY HAEMAPHYSALIS TURTURIS, HAEMAPHYSALIS PAPUANA KINNEARI AND HAEMAPHYSALIS MINUTA.
    SINGH KR; PAVRI KM; ANDERSON CR
    Indian J Med Res; 1964 Jun; 52():566-73. PubMed ID: 14184087
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the field experience with formalin-inactivated mouse brain vaccine of Russian spring-summer encephalitis virus against Kyasanur Forest disease.
    SHAH KV; ANIKER SP; MURTHY DP; RODRIGUES FM; JAYADEVIAH MS; PRASANNA HA
    Indian J Med Res; 1962 Mar; 50():162-74. PubMed ID: 13911122
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of viruses of the tick-borne encephalitis complex. II. Disease and immune responses in man following accidental infection with Kyasanur Forest disease virus.
    MORSE LJ; RUSS SB; NEEDY CF; BUESCHER EL
    J Immunol; 1962 Feb; 88():240-8. PubMed ID: 14476341
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinico-pathological observations on monkeys infected with Kyasanur Forest disease virus, with special reference to the haemopoietic system.
    WEBB HE; CHATERJEA JB
    Br J Haematol; 1962 Oct; 8():401-13. PubMed ID: 13999331
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical & epidemiological significance of Kyasanur forest disease.
    Munivenkatappa A; Sahay RR; Yadav PD; Viswanathan R; Mourya DT
    Indian J Med Res; 2018 Aug; 148(2):145-150. PubMed ID: 30381537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Langat E5 virus as a live virus vaccine against Kyasanur Forest disease virus.
    Thind IS
    Indian J Med Res; 1981 Feb; 73():141-9. PubMed ID: 6263797
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the structural protein gene sequence shows Kyasanur Forest disease virus as a distinct member in the tick-borne encephalitis virus serocomplex.
    Venugopal K; Gritsun T; Lashkevich VA; Gould EA
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():227-32. PubMed ID: 8113732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the possibility of preparing a vaccine against tick-borne encephalitis, using tissue culture methods. I. Propagation of tick-borne encephalitis virus in tissue cultures for vaccine preparation.
    DANES L; BENDA R
    Acta Virol; 1960 Jan; 4():25-36. PubMed ID: 13849502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.